iOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patients with unmet medical need
Launched as a spinout from Merck KGaA in 2017, iOnoctura is a late stage preclinical immuno-oncology company developing next generation best-in-class...